Glutamine synthetase (GS), the enzyme that catalyses glutamine synthesis from glutamate and ammonia, plays a central role in the detoxification of brain ammonia.
Oligodendrocytes (OL) form the myelin sheath in the central nervous system (CNS) and are essential for efficient propagation of nerve impulses. In culture, OL arise from bipotential O-2A progenitor cells. These O-2A cells give rise to type-2 astrocytes in the presence of serum. GS is expressed in mature glial cells [3] [4] [5] [6] [7] in vivo and in vitro, but it is unknown whether GS is present in glial progenitors. In addition, a comparison of the GS expression level among the various types of glial cells has never been done in vitro. The current study investigates in vitro GS expression levels in O-2A progenitors, astrocytes and OL. We demonstrate that the GS gene is expressed in O-2A progenitors and is expressed at different levels in each cultured glial cell type. GS also is stimulated during OL developmental maturation. Thus, the GS gene is expressed in O-2A cells and is regulated in a developmental and macroglial cell typespecific manner.
In highly enriched cultures of O-2A progenitors, type-2 astrocytes, OL or type-1 astrocytes, we investigated GS expression by double immunostaining with glial specific markers and a GS antibody. Double immunolabelling with GS ( Figure 1a ) and glial fibrillary acidic protein (GFAP) (Figure 1b Figure 1 ). Note that if an OL was CNP positive it was also OL-1 positive; and if an OL was MOG positive it was OL-1
+ . These data indicated that the number of cells immunostained for GS increased with OL differentiation and maturation ( Figure 2) .
Given that the GS protein was synthesized in each macroglial cell type tested (Figure 1 ), we next compared mRNA levels. GS mRNA expression was analysed by Northern blot using the glial cell line CG-4. Only one GS mRNA species (2.8 kb) was expressed in CG-4-derived O-2A cells, CG-4-derived type-2 astrocytes, and CG-4-derived OL, compared to two GS mRNA species (2.8 kb and 1.4 kb) that were expressed in type-1 astrocytes. Autoradiogram quantification showed that CG-4-derived O-2A progenitors expressed 20-fold less GS mRNA than CG-4-derived type-2 astrocytes and 30-fold less than CG-4-derived OL ( Figure  3b ). Thus, CG-4-derived type-2 astrocytes expressed 1.5-fold less GS mRNA than CG-4 derived OL (Figure 3b ).
To determine whether GS was functional and equally efficient in all glial cell types, GS activity was determined and compared in type-1 astrocyte primary cultures, O-2A progenitors, type-2 astrocyte and OL secondary cultures (Figure 4 ). GS activity in O-2A cells and type-1 astrocytes was similar. This level was half of that measured in type-2 astrocytes and OL which are two cell types differentiated from bipotential glial O-2A progenitors. GS activity in the latter two cell types was similar. Note that type-2 astrocytes expressed 1.5-fold less GS mRNA, but demonstrated the same GS specific activity as OL (Figure 3b ).
Previous studies indicated that GS activity was upregulated by bFGF in type-1 astrocytes but not in OL secondary cultures. 4 Since O-2A progenitors were maintained in culture medium containing bFGF, it was necessary to determine whether GS activity was dependent on bFGF. Therefore, we measured GS activity in secondary cultures highly enriched with O-2A progenitors maintained with or without bFGF (2 ng ml −1 ). GS specific activity was similar in O-2A cells grown, either in the presence of bFGF (0.10 ± 0.03 mol mg protein ) (average ± s.d. from 10 separate experiments). These data suggested that bFGF had no effect on GS expression in O-2A progenitor cells.
The CG-4 cell line proved to be interesting for this study because it expressed OL differentiation markers. Indeed, in culture, the CG-4 cell line yielded a high percent of each cell type studied. Ninety eight percent were A2B5 + /galactocerebroside (GC) − O-2A cells in serum-free medium. Upon growth factor omission, most cells (98%) acquired a typical differentiated OL (GC + ) phenotype or, in the presence of 20% FCS, a type-2 astrocytes phenotype. 9 Primary and secondary culture of O-2A progenitors, type-2 astrocytes, OL or type-1 astrocytes, contained also a high percent of each studied cell type and less than 1% of microglia as previously described. 3 The present results showed that functional GS was expressed in vitro, not only in one macroglial cell type, but in all including O-2A cells. Previously, it was thought that GS was expressed only in mature macroglial cells and not in O-2A progenitors. Thus, in these studies, we report the novel finding that GS was expressed and was highly efficient in O-2A cells. The original GS protein expression study reported that it was only found in astrocytes. 11 Later studies, 3, 4, 12, 13 using GS immunostaining or enzyme activity, found that in vivo and in vitro GS was expressed in OL as well as astrocytes. This GS protein likely also plays an important role in OL development and maturation because the protein is already enzymatically active in O-2A progenitors. The enrichment of GS mRNA in glutamatergic areas in the CNS, and the role of the GS enzyme in neurotransmitter metabolism and brain ammonia detoxification have already been described. 7 Moreover, the discovery of glutamate receptors in O-2A cells 14 is consistent with our results which show GS mRNA and active protein in O-2A progenitors.
The results presented here indicate that GS expression was differentially regulated in cultured macroglial cell types. In O-2A progenitors, GS activity was not increased by bFGF which indicated that a differential regulation of GS activity by bFGF existed among various glial cell types. Indeed, Fressinaud et al 4 showed that GS activity was also not regulated by bFGF in OL secondary cultures, but was upregulated in type-1 astrocytes. Thus, GS gene expression was likely regulated by bFGF in a macroglial cell type-specific manner.
Furthermore, in OL secondary cultures which contained cells at all stages of differentiation and development, we demonstrated that the number of cells expressing GS protein increased during OL maturation. These cultures showed that 70% of more mature (MOG + ) cells expressed GS. However, only 10% of OL-1 + cells which comprise immature cells, expressed GS. Thus, during OL maturation in vitro, GS was expressed at a stage preceding MOG expression. We noted that another protein, the growth-associated protein-43 (GAP-43), an abundant membrane phosphoprotein of the CNS, was also expressed in type-1 astrocytes, type-2 astrocytes, OL and O-2A progenitors, and its expression was developmentally and cell-specifically regulated. 15, 16 In addition, the developmental timecourse of mRNA encoding GS in vitro in type-1 astrocytes 17 was similar to the one described here for OL. In conclusion, our data strongly indicated that GS was expressed and was functional not only in type-1 astrocytes, but also in type-2 astrocytes, OL, and O-2A progenitors. However, GS gene expression and GS gene regulation were cell type-specific and developmentally regulated suggesting multiple roles or functions in the various macroglial cell types. The finding that the GS gene was subject to cell type-specific regulation broadens the number of potential biological metabolic pathways that this enzyme could subserve in vivo. This might be expected, since the regulation of ammonia levels is of great importance. Additionally, in the brain, GS may play a major role in glutamate metabolism. Myelination requires that myelin components, purines, pyrimidines, and amino acids be synthesized. This can be done in part by the GS pathway. Thus, these data indicate that GS is not only involved in later myelination, but that GS is also likely an early OL differentiation marker. ) were replated in Falcon Petri dishes (Becton Dickinson and Co, Oxnard, CA, USA) precoated with poly-l-lysine (60 000 Da, Sigma Chemicals, St Louis, MO, USA, 20 g ml −1 in 0.1 M sodium borate-NaOH buffer, pH 8.4). 20 After 30 min, the calf serum-containing medium was removed and replaced with a chemically defined medium, 20 to which 2 ng ml −1 of basic fibroblast growth factor (bFGF) was added. After 2 days in this medium (13 days, total time in culture) 80-90% of cells were A2B5 + . Type-2 astrocyte secondary cultures were prepared by modification of the Deloulme et al 18 method and using high density O-2A progenitor cell cultures prepared as previously described. These cells were grown for 2 days in the chemically defined medium described above with 2 ng ml −1 bFGF added. Then, DMEM was removed and DMEM supplemented with 15% fetal calf serum (FCS) was added. Eighty to eighty-five percent of O-2A precursor cells differentiated into glial fibrillary acidic protein (GFAP + )-containing type-2 astrocytes within 3 days (16 days, total time in culture).
Methods

Cell culture
To obtain OL secondary cultures, OL were dislodged from 22-day primary mixed glial cell cultures 18, 21 and plated for 2 h as described for O-2A progenitor cells. After 2 h, the serum-containing medium was removed and the chemically defined medium added. OL secondary cultures (10 5 cells per cm 2 ) were grown in the chemically defined medium which was changed every 3 days. The OL secondary culture system used in this study was highly selective for the OL lineage. After 4 days in chemically defined medium (26 days, total time in culture), these subcultures contained at least 85% GC-or CNP-positive OL. 20, 22 In addition, about 70% and 24% of these cells expressed MBP and MOG, respectively. Both antigens were expressed after GC during OL maturation in vitro. 23, 24 OL secondary cultures also contained O-2A progenitor cells (10-15% A2B5
+ cells) and a small proportion of astrocytes and microglia (Ͻ1.5% each) as previously described. 18, 21 Primary type-1 astrocyte cultures were prepared by modification of the Booher and Sensenbrenner method. 25 Cells were plated at a density of 5 × 10 3 cells per cm 2 in Falcon Petri dishes. Culture medium was changed after 5 days and then twice a week. After 22 days in culture, 95% of the cells were positively stained for GFAP. Astrocyte cultures were maintained in the chemically defined medium. After 24 h in this defined medium, the medium was changed and the cells were maintained for 3 additional days (ie, 23-26 days, total time).
The CG-4 cell line was routinely cultured in DMEM supplemented with N1 biotin as described by Louis et al. 9 Nearly all cells were maintained as self-renewing O-2A progenitors (98% are A2B5 + /GC − ) in serum-free medium by concurrent treatment with platelet-derived growth factor (PDGF) (5 ng ml −1 ) and bFGF (5 ng ml −1 ) as described. 26 Upon PDGF and bFGF removal, CG-4 cells differentiated readily into OL. After 2 days, most cells (98%) acquired a typical OL differentiated phenotype (GC + ). Forty-eight hours after growth factor withdrawal, 2% FCS was added to promote oligodendrocyte survival and maturation. To induce O-2A progenitor cells to differentiate into type-2 astrocytes (A2B5 + /GFAP + cells), 20% FCS was added to the medium after growth factor withdrawal. 9 
Immunocytochemistry
Immunostaining for the O-2A progenitors characteristic for A2B5 mouse monoclonal antibody (mAb), the unknown sulfatide OL-1 characteristic for immature OL rat mAb, the mature OL specific MOG mouse mAb, the rabbit anti-GS polyclonal antibody, the mature OL specific SMI 99 mAb anti-MBP or mouse mAb anti-GFAP was performed as previously described. 26, 27 Double immunolabelling with polyclonal guinea pig antirat brain myelin CNP antibody prepared by Dr NM Neskovic in our laboratory (1/50 dilution, 1 h at RT) was done with anti-guinea pig IgG (1/100 dilution, Biosys SA, France) in the same manner as MBP double immunolabelling. After further washing in PBS, coverslips were mounted in 58% glycerol in PBS, viewed and photographed using an epifluorescence illumination.
Other analyses
Glutamine synthetase activity was determined in crude cell extracts according to Perraud et al. 28 To analyze the expression of mRNAs coding for GS, a 1300-bp EcoRI/PstI cDNA fragment inserted into pBR322 7 was radiolabelled by random priming with 32 P-dCTP (NEN, 3000 Ci mmol −1 , Les Ulis, France) using a random priming kit (BRL, Cergy Pontoise, France). Poly(A) + mRNA was prepared as described by Hartmann et al. 29 Five micrograms of mRNA were electrophoresed on a 1% agarose gel (20 mM MOPS, 5 mM sodium acetate, 1 mM EDTA, pH 7.0, 0.66 M formaldehyde). The RNAs were transferred onto nylon and blots were hybridized at 42°C overnight with 2 × 10 6 cpm ml −1 of 32 P-labelled cDNA in 50% deionized formamide, 50 mM NaH 2 PO 4 , pH 7.4, 1 mM EDTA, 0.75 M NaCl, 1% Denhardt's, 0.1% SDS. Blots were washed twice at room temperature in 1× sodium salt citrate (SSC), then once with 1× SSC, 1% SDS for 20 min at 42°C and twice with 1× SSC, 1% SDS for 20 min at 50°C. Blots were autoradiographed on Kodak XAR5 film at −70°C. Relative mRNA levels were quantitated on autoradiograms by densitometry. The recovery of mRNAs was determined by hybridization with a probe for cyclophilin, an unrelated gene constitutively expressed in all animal cells. 10 All values were normalized to the cyclophilin signal.
